-
<![CDATA[How Modern Research Is Transforming Metastatic HER2+ Breast Cancer Care]]>
20 Dec 2025 01:16 GMT
… kinase inhibitors: Tykerb (lapatinib), Nerlynx (neratinib) and … DESTINY-Breast06 (NCT04494425) trial.
“Antibody-drug conjugate, [Enhertu] … trials.
The Full Circle With HER2-Positive Breast Cancer Treatment … England Journal of Medicine.
"Trastuzumab …
-
Metastatic Cancer Drugs Market Expanding With $74.71 Billion at 5.6% CAGR by 2029
25 Nov 2025 00:00 GMT
… the success of clinical trials, and upgrades in … the rise of precision medicine, development of biomarker … in biotech and pharmaceuticals, launched a drug for breast cancer treatment … Trastuzumab, Ado-trastuzumab emtansine, Lapatinib
2) By Immune Checkpoint …
-
Delayed Cardiac Dysfunction During Prolonged Use of Trastuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer
25 Nov 2025 17:43 GMT
… Caiwen Du, Department of Medical Oncology, National Cancer Center… included pertuzumab (n=26), lapatinib (n=36), pyrotinib (n … antibody–drug conjugates in later-line treatment.
Table 2 Treatment History … used in previous clinical trials for patients receiving …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… NSCLC cells.71
Medication Delivery Utilizing Active … in cancer diagnosis and treatment. Pharmaceutics. 2023;15(3):1025 … chitosan for cancer nano drug delivery. Biotechnol Adv. 2023;67 … A. Precision Nanomedicine: lapatinib-Loaded Chitosan-Gold Nanoparticles …
-
Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell
17 Dec 2025 14:00 GMT
… multiple early-stage biotech companies in precision oncology … Member of Zentalis Pharmaceuticals, Chief Medical Officer at Tempus … pioneering targeted therapies including lapatinib and T-DM1 … control company advancing precision treatments that target the …
-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… resists conventional treatments. Microcatheter-assisted drug-loaded microspheres … drug concentrations.8 Lapatinib lipid microspheres enhance drug … doi:10.3390/pharmaceutics14020359.
10. Nicoletti R, … al. Intradermal DNA vaccination combined with dual …
-
Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)
17 Sep 2025 17:44 GMT
… months in clinical trials.2,3 Despite this … -DXd), an antibody-drug conjugate linking trastuzumab to … chemotherapy (eg, vinorelbine), lapatinib/capecitabine combinations, or … treatment and any medical condition deemed to compromise patient safety or trial …
-
Investigation of Thrombocytopenia Associated with Trastuzumab Emtansine Treatment in Breast Cancer: A Retrospective Study in a Chinese Population
04 Sep 2025 21:52 GMT
… recent years, antibody-drug conjugates (ADCs) have … treatment combinations, such as trastuzumab plus docetaxel2 or lapatinib … included demographic characteristics, medical history, laboratory results, … controlled trials. For example, the EMILIA trial reported …
-
Determination of 5-Fluorouracil in Dried Blood Spots for Therapeutic Drug Monitoring and Adverse Event Assessment in Breast Cancer Patients
29 Aug 2025 09:00 GMT
… anticancer therapy such as lapatinib, anastrozole, and letrozole … traditional Chinese medicines for colorectal cancer treatment. Integr … practice: analysis of drugs and pharmaceutical formulations. Futur J … 47;/www.fda.gov/vaccines-blood-biologics…
-
Lapatinib and NNC 55-0396 Boost Gastric Cancer Fight
07 Aug 2025 14:20 GMT
… biomarker-driven precision medicine. Given the heterogeneous … for rigorous clinical trials to validate safety, … repurposing existing drugs—such as lapatinib, already approved … adenocarcinoma researchgastric cancer treatment advancementsimproving survival rates …